BackRELIEF THERAPEUTICS HOLDING ORD SHS Overview

RELIEF THERAPEUTICS HOLDING ORD SHS Current Assets

Latest current assets for RLFTF: $13M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$12.77M
↓ 15.92% YoYΔ $-2.42M vs prior year quarter

Peer trimmed avg / median

Loading

RELIEF THERAPEUTICS HOLDING ORD SHS Current Assets History

Loading

RELIEF THERAPEUTICS HOLDING ORD SHS vs. peers: Current Assets Comparison

Loading

RELIEF THERAPEUTICS HOLDING ORD SHS Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RELIEF THERAPEUTICS HOLDING ORD SHS (RLFTF) FAQ

RELIEF THERAPEUTICS HOLDING ORD SHS posts a current assets of $13M as of June 2026. That compares with $15M in the prior-year period — down 15.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, RELIEF THERAPEUTICS HOLDING ORD SHS's current assets was $15M. The latest reading is $13M — a 15.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of RELIEF THERAPEUTICS HOLDING ORD SHS's financial statement story. At $13M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for RLFTF's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; RELIEF THERAPEUTICS HOLDING ORD SHS's other metric pages and overview cover the third.

Judging RELIEF THERAPEUTICS HOLDING ORD SHS against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $13M here, then scan peer and history charts to see if the gap is persistent.